EichorEICHOR
Location: Seongnam Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Seongnam

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Phase N/A · CHA Bundang Medical Center · Eisai Korea Inc. · NCT06246123KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W
Phase 1/Phase 2 · Seoul National University Bundang Hospital ( Site 0081) · Merck Sharp & Dohme LLC · NCT04165070A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Seoul National University Bundang Hospital · Eli Lilly and Company · NCT07218380Effect of oXiris Hemofilter Use in Septic Shock: A Multicenter Retrospective Cohort Study
Phase N/A · Seoul National University Bundang Hospital · Seoul National University Bundang Hospital · NCT07539883This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Seoul National University Bundang Hospital · Pfizer · NCT07028853A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurr
Phase 2 · Bundang Seoul National University Hospital · Yonsei University · NCT06023862This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Seoul National University Bundang Hospital · Pfizer · NCT06758401Study of WAL0921 in Patients With Glomerular Kidney Diseases
Phase 2 · Seoul National University Bundang Hospital · Walden Biosciences · NCT06466135A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Gr
Phase 2 · CHA Bundang Medical Center /ID# 271590 · AbbVie · NCT06682988Cohort Study for Gastric MALT Lymphoma
Phase N/A · Cheol Min Shin · Seoul National University Hospital · NCT06454149PulseSelect™ PFA Global Registry
Phase N/A · Seoul National University Bundang Hospital · Medtronic Cardiac Ablation Solutions · NCT06393920Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
Phase 1 · Bundang CHA General Hospital · Aribio Lab Co., Ltd. · NCT06137755A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants Wit
Phase 1/Phase 2 · Local Institution - 0027 · Bristol-Myers Squibb · NCT07291076Double Unit Cord Blood Transplant in Hematologic Malignancies.
Phase N/A · Seoul National University Bundang Hospital · Seoul National University Hospital · NCT06712108A Study of Olanzapine in Participants With Bipolar Disorder.
Phase N/A · CHA Bundang Medical Center · Boryung Pharmaceutical Co., Ltd · NCT07263191The DECISION-CTO Extended 10 Y Follow-up
Phase N/A · Bundang CHA Hospital · Seung-Jung Park · NCT06908499Predictors of Prognosis in IBD Patients
Phase N/A · Seoul National University Bundang Hospital · Seoul National University Bundang Hospital · NCT05653011Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Seoul National University Bundang Hospital · Eli Lilly and Company · NCT06890598Quality of Pediatric Resuscitation in a Multicenter Collaborative
Phase N/A · Seoul National University Bundang Hospital · Children's Hospital of Philadelphia · NCT02708134A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorecta
Phase 1 · Seoul National University Bundang Hospital · Hoffmann-La Roche · NCT04929223A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Seoul National University Bundang Hospital · Pfizer · NCT07144280A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Seoul National University Bundang Hospital-Medical Oncology · Merck Sharp & Dohme LLC · NCT06077760A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Local Institution - 0102 · Celgene · NCT05519085Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · Seoul National University Bundang Hospital · Gilead Sciences · NCT06051617Fostrox Plus Lenvatinib vs Lenvatinib in Advanced Hepatocellular Carcinoma After First-line Immunotherapy
Phase 2 · CHA Bundang Medical Center · CHA University · NCT07493668Tegoprazan-containing Sequential for H. Pylori
NA · Seoul National University Bundang Hospital · Seoul National University Bundang Hospital · NCT06382493A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Phase 3 · Seoul National University Bundang Hospital · Bristol-Myers Squibb · NCT06976216EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · CHA Bundang Medical Center · Boehringer Ingelheim · NCT06531824Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Phase N/A · Seoul National University Bundang Hospital · Chong Kun Dang Pharmaceutical · NCT06838286A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Phase 3 · Seoul National University Bundang Hospital · Eli Lilly and Company · NCT06672549
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.